{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:41:55Z","timestamp":1740141715526,"version":"3.37.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T00:00:00Z","timestamp":1549324800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004612","name":"Funda\u00e7\u00e3o Arauc\u00e1ria","doi-asserted-by":"publisher","award":["05\/2011-22721"],"award-info":[{"award-number":["05\/2011-22721"]}],"id":[{"id":"10.13039\/501100004612","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12981-019-0219-1","type":"journal-article","created":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T08:03:28Z","timestamp":1549353808000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Moderate prevalence of HIV-1 transmitted drug resistance mutations in southern Brazil"],"prefix":"10.1186","volume":"16","author":[{"given":"Larissa Danielle","family":"Bahls","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro Henrique","family":"Canezin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edna Maria Vissoci","family":"Reiche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Carlos Couto","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Ricardo Colleti","family":"Dias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera Alice Fernandes","family":"Meneguetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Toshio","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis Armando","family":"Bertolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,5]]},"reference":[{"key":"219_CR1","unstructured":"WHO. UNAIDS Data 2017. Geneva: Joint United NationsProgramme on HIV\/AIDS; 2017."},{"key":"219_CR2","unstructured":"Brasil. Boletim epidemiol\u00f3gico HIV\/Aids 2018. Brasilia: Minist\u00e9rio da Sa\u00fade; 2018."},{"issue":"5","key":"219_CR3","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S1473-3099(11)70032-9","volume":"11","author":"L Wittkop","year":"2011","unstructured":"Wittkop L, Gunthard HF, de Wolf F, Dunn D, Cozzi-Lepri A, de Luca A, et al. Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study. Lancet Infect Dis. 2011;11(5):363\u201371.","journal-title":"Lancet Infect Dis."},{"issue":"Suppl 1","key":"219_CR4","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.4081\/idr.2013.s1.e5","volume":"5","author":"PS Pennings","year":"2013","unstructured":"Pennings PS. HIV drug resistance: problems and perspectives. Infect Dis Rep. 2013;5(Suppl 1):e5.","journal-title":"Infect Dis Rep."},{"issue":"9","key":"219_CR5","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1086\/496984","volume":"41","author":"PE Sax","year":"2005","unstructured":"Sax PE, Islam R, Walensky RP, Losina E, Weinstein MC, Goldie SJ, et al. Should resistance testing be performed for treatment-naive HIV-infected patients? A cost-effectiveness analysis. Clin Infect Dis. 2005;41(9):1316\u201323.","journal-title":"Clin Infect Dis."},{"issue":"2","key":"219_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/hiv.12322","volume":"17","author":"L Ryom","year":"2016","unstructured":"Ryom L, Boesecke C, Gisler V, Manzardo C, Rockstroh JK, Puoti M, et al. Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV-positive persons. HIV Med. 2016;17(2):83\u20138.","journal-title":"HIV Med."},{"issue":"2","key":"219_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1001\/jama.2016.8900","volume":"316","author":"HF G\u00fcnthard","year":"2016","unstructured":"G\u00fcnthard HF, Saag MS, Benson CA, del Rio C, Eron JJ, Gallant JE, et al. Antiretroviral drugs for treatment and prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel. JAMA. 2016;316(2):191\u2013210.","journal-title":"JAMA"},{"issue":"8","key":"219_CR8","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1093\/cid\/cix056","volume":"64","author":"LM Hofstra","year":"2017","unstructured":"Hofstra LM, S\u00e1nchez Rivas E, Nijhuis M, Bank LEA, Wilkinson E, Kelly K, et al. High rates of transmission of drug-resistant HIV in Aruba resulting in reduced susceptibility to the WHO Recommended First-line Regimen in Nearly Half of Newly Diagnosed HIV-infected Patients. Clin Infect Dis. 2017;64(8):1092\u20137.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"219_CR9","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1002\/jmv.24087","volume":"87","author":"ME Moura","year":"2015","unstructured":"Moura ME, da Guarda Reis MN, Lima YA, Eul\u00e1lio KD, Cardoso LP, Stefani MM. HIV-1 transmitted drug resistance and genetic diversity among patients from Piau\u00ed State, Northeast Brazil. J Med Virol. 2015;87(5):798\u2013806.","journal-title":"J Med Virol."},{"issue":"2","key":"219_CR10","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1089\/aid.2014.0261","volume":"31","author":"ME Moura","year":"2015","unstructured":"Moura ME, Reis MN, Lima YA, Eul\u00e1lio KD, Cardoso LP, Stefani MM. Low rate of transmitted drug resistance may indicate low access to antiretroviral treatment in Maranh\u00e3o State, northeast Brazil. AIDS Res Hum Retroviruses. 2015;31(2):250\u20134.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"9","key":"219_CR11","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1089\/aid.2009.0012","volume":"25","author":"E Sprinz","year":"2009","unstructured":"Sprinz E, Netto EM, Patelli M, Lima JS, Lima MP, Furtado JJ, et al. Primary antiretroviral drug resistance among HIV type 1-infected individuals in Brazil. AIDS Res Hum Retroviruses. 2009;25(9):861\u20137.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"10","key":"219_CR12","doi-asserted-by":"publisher","first-page":"e25869","DOI":"10.1371\/journal.pone.0025869","volume":"6","author":"SS Sanabani","year":"2011","unstructured":"Sanabani SS, Pastena \u00c9, da Costa AC, Martinez VP, Kleine-Neto W, de Oliveira AC, et al. Characterization of partial and near full-length genomes of HIV-1 strains sampled from recently infected individuals in S\u00e3o Paulo, Brazil. PLoS ONE. 2011;6(10):e25869.","journal-title":"PLoS ONE"},{"issue":"4","key":"219_CR13","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1089\/aid.2011.0333","volume":"29","author":"JH Pilotto","year":"2013","unstructured":"Pilotto JH, Grinsztejn B, Veloso VG, Velasque LS, Friedman RK, Moreira RI, et al. Moderate prevalence of transmitted drug resistance mutations among antiretroviral-naive HIV-infected pregnant women in Rio de Janeiro. Brazil. AIDS Res Hum Retroviruses. 2013;29(4):681\u20136.","journal-title":"Brazil. AIDS Res Hum Retroviruses."},{"key":"219_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1758-2652-12-20","volume":"12","author":"LA Inocencio","year":"2009","unstructured":"Inocencio LA, Pereira AA, Sucupira MC, Fernandez JC, Jorge CP, Souza DF, et al. Brazilian network for HIV drug Resistance Surveillance: a survey of individuals recently diagnosed with HIV. J Int AIDS Soc. 2009;12:20.","journal-title":"J Int AIDS Soc."},{"key":"219_CR15","unstructured":"Brasil. Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas para Manejo da Infec\u00e7\u00e3o pelo HIV em Adultos. In: sa\u00fade Md, editor. Brasilia, 2017."},{"issue":"11","key":"219_CR16","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1097\/QAD.0b013e32832d40ad","volume":"23","author":"S Yerly","year":"2009","unstructured":"Yerly S, Junier T, Gayet-Ageron A, Amari EB, von Wyl V, G\u00fcnthard HF, et al. The impact of transmission clusters on primary drug resistance in newly diagnosed HIV-1 infection. AIDS. 2009;23(11):1415\u201323.","journal-title":"AIDS."},{"issue":"4","key":"219_CR17","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1590\/S0036-46652012000400005","volume":"54","author":"KV Gaspareto","year":"2012","unstructured":"Gaspareto KV, Mello FM, Dias JR, Meneguetti VA, Storti ME, Ferreira JL, et al. Genetic diversity and primary resistance among HIV-1-positive patients from Maring\u00e1, Paran\u00e1, Brazil. Rev Inst Med Trop Sao Paulo. 2012;54(4):207\u201313.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"219_CR18","first-page":"75","volume":"70","author":"SR Swindell","year":"1997","unstructured":"Swindell SR, Plasterer TN. SEQMAN. Contig assembly. Methods Mol Biol. 1997;70:75\u201389.","journal-title":"Methods Mol Biol"},{"issue":"19","key":"219_CR19","doi-asserted-by":"publisher","first-page":"3797","DOI":"10.1093\/bioinformatics\/bti607","volume":"21","author":"K Oliveira de","year":"2005","unstructured":"de Oliveira K, Deforche S, Cassol M, Salminem D, Paraskevis C, Seebregts J, et al. An automated genotyping system for analysis of HIV-1 and other microbial sequences. Bioinfomatics. 2005;21(19):3797\u2013800.","journal-title":"Bioinfomatics."},{"issue":"10","key":"219_CR20","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1093\/molbev\/msr121","volume":"28","author":"K Tamura","year":"2011","unstructured":"Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011;28(10):2731\u20139.","journal-title":"Mol Biol Evol"},{"key":"219_CR21","unstructured":"Los Alamos HIV sequence database. (\n                    http:\/\/www.hiv.lanl.gov\/\n                    \n                  ) Accessed 15 Aug 2013."},{"issue":"11","key":"219_CR22","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1089\/aid.1995.11.1413","volume":"11","author":"AC Siepel","year":"1995","unstructured":"Siepel AC, Halpern AL, Macken C, Korber BT. A computer program designed to screen rapidly for HIV type 1 intersubtype recombinant sequences. AIDS Res Hum Retroviruses. 1995;11(11):1413\u20136.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"219_CR23","doi-asserted-by":"crossref","unstructured":"Gifford RJ, Liu TF, Rhee SY, Kiuchi M, Hue S, Pillay D, et al. The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistance. Bioinformatics. 2009;25(9):1197-8. (\n                    http:\/\/cpr.stanford.edu\/cpr.cgi\n                    \n                  ). Accessed 15 Aug 2013.","DOI":"10.1093\/bioinformatics\/btp134"},{"key":"219_CR24","unstructured":"HIV-1 genotypic drug resistence interpretation\u2019s algorithms. French National Agency for AIDS Research. (\n                    http:\/\/www.hivfrenchresistance.org\/index.html\n                    \n                  ). Accessed 15 Aug 2013."},{"issue":"3","key":"219_CR25","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1177\/003335490912400320","volume":"124","author":"KM Sullivan","year":"2009","unstructured":"Sullivan KM, Dean A, Soe MM. OpenEpi: a web-based epidemiologic and statistical calculator for public health. Public Health Rep. 2009;124(3):471\u20134.","journal-title":"Public Health Rep"},{"issue":"4","key":"219_CR26","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/01.qai.0000219290.49152.6a","volume":"41","author":"A Shet","year":"2006","unstructured":"Shet A, Berry L, Mohri H, Mehandru S, Chung C, Kim A, et al. Tracking the prevalence of transmitted antiretroviral drug-resistant HIV-1: a decade of experience. J Acquir Immune Defic Syndr. 2006;41(4):439\u201346.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"219_CR27","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1093\/jac\/dkm082","volume":"59","author":"CL Booth","year":"2007","unstructured":"Booth CL, Geretti AM. Prevalence and determinants of transmitted antiretroviral drug resistance in HIV-1 infection. J Antimicrob Chemother. 2007;59(6):1047\u201356.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"219_CR28","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/01.qai.0000221677.29693.dd","volume":"42","author":"JR Lama","year":"2006","unstructured":"Lama JR, Sanchez J, Suarez L, Caballero P, Laguna A, Sanchez JL, et al. Linking HIV and antiretroviral drug resistance surveillance in Peru: a model for a third-generation HIV sentinel surveillance. J Acquir Immune Defic Syndr. 2006;42(4):501\u20135.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"219_CR29","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1086\/510748","volume":"44","author":"D Smith","year":"2007","unstructured":"Smith D, Moini N, Pesano R, Cachay E, Aiem H, Lie Y, et al. Clinical utility of HIV standard genotyping among antiretroviral-naive individuals with unknown duration of infection. Clin Infect Dis. 2007;44(3):456\u20138.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"219_CR30","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/cid\/civ963","volume":"62","author":"LM Hofstra","year":"2016","unstructured":"Hofstra LM, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, et al. Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe. Clin Infect Dis. 2016;62(5):655\u201363.","journal-title":"Clin Infect Dis"},{"key":"219_CR31","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s13104-016-2101-8","volume":"9","author":"M Mungati","year":"2016","unstructured":"Mungati M, Mhangara M, Gonese E, Mugurungi O, Dzangare J, Ngwende S, et al. Pre-treatment drug resistance among patients initiating antiretroviral therapy (ART) in Zimbabwe: 2008-2010. BMC Res Notes. 2016;9:302.","journal-title":"BMC Res Notes."},{"key":"219_CR32","unstructured":"WHO. The HIV drug resistance report-2012. 2012."},{"key":"219_CR33","first-page":"3","volume":"2","author":"MB Arruda","year":"2018","unstructured":"Arruda MB, Boullosa LT, Cardoso CC, da Costa CM, Alves CR, de Lima ST, et al. Brazilian network for HIV drug resistance surveillance (HIV-BresNet): a survey of treatment-naive individuals. J Int AIDS Soc. 2018;2:3.","journal-title":"J Int AIDS Soc."},{"issue":"8","key":"219_CR34","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1002\/jmv.22128","volume":"83","author":"AS Ferreira","year":"2011","unstructured":"Ferreira AS, Cardoso LP, Stefani MM. Moderate prevalence of transmitted drug resistance and high HIV-1 genetic diversity in patients from Mato Grosso State, Central Western Brazil. J Med Virol. 2011;83(8):1301\u20137.","journal-title":"J Med Virol."},{"issue":"10","key":"219_CR35","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1089\/aid.2010.0334","volume":"27","author":"BC Carvalho","year":"2011","unstructured":"Carvalho BC, Cardoso LP, Damasceno S, Stefani MM. Moderate prevalence of transmitted drug resistance and interiorization of HIV type 1 subtype C in the inland North State of Tocantins, Brazil. AIDS Res Hum Retroviruses. 2011;27(10):1081\u20137.","journal-title":"AIDS Res Hum Retroviruses."},{"issue":"3","key":"219_CR36","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jcv.2011.04.011","volume":"51","author":"T Gr\u00e4f","year":"2011","unstructured":"Gr\u00e4f T, Passaes CP, Ferreira LG, Grisard EC, Morgado MG, Bello G, et al. HIV-1 genetic diversity and drug resistance among treatment na\u00efve patients from Southern Brazil: an association of HIV-1 subtypes with exposure categories. J Clin Virol. 2011;51(3):186\u201391.","journal-title":"J Clin Virol"},{"issue":"2","key":"219_CR37","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1089\/apc.2006.0079","volume":"21","author":"MC Sucupira","year":"2007","unstructured":"Sucupira MC, Caseiro MM, Alves K, Tescarollo G, Janini LM, Sabino EC, et al. High levels of primary antiretroviral resistance genotypic mutations and B\/F recombinants in Santos, Brazil. AIDS Patient Care STDS. 2007;21(2):116\u201328.","journal-title":"AIDS Patient Care STDS."},{"issue":"10","key":"219_CR38","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1002\/jmv.22188","volume":"83","author":"RM Medeiros de","year":"2011","unstructured":"de Medeiros RM, Junqueira DM, Matte MC, Barcellos NT, Chies JA, Matos Almeida SE. Co-circulation HIV-1 subtypes B, C, and CRF31_BC in a drug-na\u00efve population from Southernmost Brazil: analysis of primary resistance mutations. J Med Virol. 2011;83(10):1682\u20138.","journal-title":"J Med Virol"},{"issue":"2","key":"219_CR39","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1590\/S0074-02762002000200001","volume":"97","author":"MG Morgado","year":"2002","unstructured":"Morgado MG, Guimar\u00e3es ML, Galv\u00e3o-Castro B. HIV-1 polymorphism: a challenge for vaccine development\u2014a review. Mem Inst Oswaldo Cruz. 2002;97(2):143\u201350.","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"1","key":"219_CR40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/00002030-200301030-00004","volume":"17","author":"MA Soares","year":"2003","unstructured":"Soares MA, De Oliveira T, Brindeiro RM, Diaz RS, Sabino EC, Brigido L, et al. A specific subtype C of human immunodeficiency virus type 1 circulates in Brazil. AIDS. 2003;17(1):11\u201321.","journal-title":"AIDS."},{"issue":"2","key":"219_CR41","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2223\/JPED.1877","volume":"85","author":"FJ Almeida","year":"2009","unstructured":"Almeida FJ, Berezin EN, Rodrigues R, S\u00e1fadi MA, Arnoni MV, Oliveira C, et al. Diversity and prevalence of antiretroviral genotypic resistance mutations among HIV-1-infected children. J Pediatr (Rio J). 2009;85(2):104\u20139.","journal-title":"J Pediatr (Rio J)."},{"issue":"5","key":"219_CR42","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S1413-8670(10)70099-4","volume":"14","author":"MM Silva","year":"2010","unstructured":"Silva MM, Telles FQ, da Cunha CA, Rhame FS. HIV subtype, epidemiological and mutational correlations in patients from Paran\u00e1, Brazil. Braz J Infect Dis. 2010;14(5):495\u2013501.","journal-title":"Braz J Infect Dis."},{"issue":"3","key":"219_CR43","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jcv.2007.04.012","volume":"39","author":"MM Stefani","year":"2007","unstructured":"Stefani MM, Pereira GA, Lins JA, Alcantara KC, Silveira AA, Viegas AA, et al. Molecular screening shows extensive HIV-1 genetic diversity in Central West Brazil. J Clin Virol. 2007;39(3):205\u20139.","journal-title":"J Clin Virol"},{"issue":"1","key":"219_CR44","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1006\/viro.2000.0487","volume":"275","author":"E Caride","year":"2000","unstructured":"Caride E, Brindeiro R, Hertogs K, Larder B, Dehertogh P, Machado E, et al. Drug-resistant reverse transcriptase genotyping and phenotyping of B and non-B subtypes (F and A) of human immunodeficiency virus type I found in Brazilian patients failing HAART. Virology. 2000;275(1):107\u201315.","journal-title":"Virology"},{"issue":"2","key":"219_CR45","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1089\/aid.2006.22.207","volume":"22","author":"JC Couto-Fernandez","year":"2006","unstructured":"Couto-Fernandez JC, Eyer-Silva WA, Guimar\u00e3es ML, Chequer-Fernandez SL, Grinsztejn B, Delaporte E, et al. Phylogenetic analysis of Brazilian HIV type 1 subtype D strains: tracing the origin of this subtype in Brazil. AIDS Res Hum Retroviruses. 2006;22(2):207\u201311.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"17","key":"219_CR46","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1089\/088922202320886307","volume":"18","author":"ML Guimar\u00e3es","year":"2002","unstructured":"Guimar\u00e3es ML, Moreira A, Loureiro R, Galv\u00e3o-Castro B, Morgado MG. Characterization BNfHIa. High frequency of recombinant genomes in HIV type 1 samples from Brazilian southeastern and southern regions. AIDS Res Hum Retroviruses. 2002;18(17):1261\u20139.","journal-title":"AIDS Res Hum Retroviruses."}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-019-0219-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12981-019-0219-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-019-0219-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T19:04:59Z","timestamp":1580843099000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-019-0219-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,5]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["219"],"URL":"https:\/\/doi.org\/10.1186\/s12981-019-0219-1","relation":{},"ISSN":["1742-6405"],"issn-type":[{"type":"electronic","value":"1742-6405"}],"subject":[],"published":{"date-parts":[[2019,2,5]]},"assertion":[{"value":"15 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"4"}}